Colgate-Palmolive Company
Can Colgate rebuild U.S. volume and share and hold margins as raw material, tariff and advertising costs rise, or does growth stay dependent on emerging markets and price?
Last 4 earnings calls · through Q2 FY2026
Bull case
Emerging market brand strength
The bull case is that Colgate's brands and emerging market scale let it take share and raise prices even where category growth is weak.
Hill's premium pet nutrition
Hill's science-led pet nutrition keeps growing faster than a flat category, giving the company a premium business that carries higher margins.
Cash funds brand investment
Cash generation is strong enough to fund higher advertising, absorb commodity inflation and still return most free cash flow to shareholders.
Productivity offsets cost inflation
Management has raised its margin guidance and expanded a productivity program, which supports the argument that earnings can grow even in a slow market.
Bear case
U.S. share and shipment losses
The bear case is that North America has repeatedly missed the recovery management expected, with share losses and retailer destocking cutting shipments.
Slower category growth
Category growth has settled at roughly half its historical rate, which invites more couponing and price competition across the company's core categories.
Rising input and tariff costs
Raw material, logistics and tariff costs keep rising, so gross margin gains depend on pricing and productivity that may not repeat.
Dependence on cost savings
Earnings growth relies on cost programs offsetting inflation while advertising rises, leaving little room if commodity prices move further.
Bull and bear points
Growth & Execution
In short: Emerging markets and Hill's are growing, while the U.S. business keeps missing its planned recovery.
Emerging markets lead the volume acceleration
Revenue grew 4.9% in the second quarter, with management reporting mid-single-digit sales growth in India, Brazil, Mexico and China. Those markets carry higher shares and scale, so they drive the consolidated growth rate.
Q2 FY2026 callHill's keeps outgrowing a flat pet category
Hill's organic sales ex-private label grew about 4% against a flat U.S. category, with the therapeutic Prescription Diet line up double digits. That mix lifts the division's operating margin while the rest of pet food stalls.
Q2 FY2026 call
The promised North America recovery keeps slipping
Management previously said U.S. categories had bottomed and would return slowly; on the latest call it called the second quarter disappointing and pushed improvement into the back half. Each delay leaves more of the growth burden on emerging markets.
Tone shiftQ4 FY2025 → Q2 FY2026New products and shelf resets arrived later than planned
Management said late shelf resets and late first-quarter shipments dampened North America volume. Innovation timing matters because the U.S. recovery plan depends on premium launches reaching shelves on schedule.
Q1 FY2026 call
Profitability & Financial Strength
In short: Gross margin and cash flow are rising while advertising and tariff costs pressure operating margin.
Full-year gross margin guidance moved from down to flat
Gross margin reached 61.5% in the second quarter, up 1.4 points, and management lifted the full-year outlook from a decline to roughly flat. Better than expected pricing, mix and productivity drove the change.
Tone shiftQ1 FY2026 → Q2 FY2026Shareholder cash returns are internally funded
The company returned $3.1 billion to shareholders over the last twelve months, equal to 81% of free cash flow, and that cash came from operations rather than borrowing. It shows the dividend and buyback can continue while advertising and productivity spending are also funded.
Filed financials
Operating margin fell even as gross margin rose
Operating margin dropped 2.2 points to 19.0% because higher advertising and tariff costs outweighed the gross margin gain. The company is converting its gross profit improvement into brand spending rather than into operating profit.
Filed financialsSecond-half costs rise as the refunds fade
Management expects raw material and tariff costs to be higher in the second half than in the second quarter, and said the second-quarter gross margin included tariff refunds that will be insignificant going forward. Holding margins depends on pricing and savings landing on time.
Q2 FY2026 call
Market Position
In short: Brands hold leading shares, but slow category growth invites heavier promotion and retailer pressure.
Super premium brands give pricing power in Europe
Elmex and Meridol sell at super premium prices in Europe, where management says the premium end of toothpaste is the growing part of the market. That portfolio is the model Colgate wants to copy in the U.S., where it is under-indexed.
Q2 FY2026 callBrand support went from cutback to a double-digit increase
Management trimmed advertising in 2025 when categories slowed, then raised spending by double digits in the second quarter with more planned for the second half. Sustained support defends share against competitors now spending more on coupons.
Tone shiftQ4 FY2025 → Q2 FY2026
Category growth has settled below its historical rate
Management puts category growth at 1.5% to 2.5%, well under the 3% to 5% long-term rate it has used, and expects that slower pace to draw more promotion from competitors and retailers. Colgate's own plans assume no big rebound in the U.S.
Q4 FY2025 callTariffs fall mostly on the North America business
US executive-order tariffs and partner retaliation raise costs and consumer uncertainty, and management says North America absorbs the vast majority of the tariff bill. That concentrates the cost on the region already struggling with share.
10-K, filed 2026-02-23